TD Waterhouse Canada Inc. Has $4.40 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

TD Waterhouse Canada Inc. decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 14,658 shares of the company's stock after selling 905 shares during the quarter. TD Waterhouse Canada Inc.'s holdings in HCA Healthcare were worth $4,401,000 as of its most recent SEC filing.

A number of other institutional investors have also bought and sold shares of the business. Whipplewood Advisors LLC purchased a new position in HCA Healthcare in the fourth quarter worth approximately $31,000. Tidemark LLC acquired a new position in shares of HCA Healthcare in the fourth quarter valued at approximately $36,000. Activest Wealth Management grew its stake in shares of HCA Healthcare by 1,250.0% in the fourth quarter. Activest Wealth Management now owns 135 shares of the company's stock worth $40,000 after acquiring an additional 125 shares in the last quarter. Pinnacle Bancorp Inc. grew its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company's stock worth $45,000 after purchasing an additional 50 shares in the last quarter. Finally, Eastern Bank acquired a new position in HCA Healthcare during the 4th quarter worth approximately $62,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on the company. KeyCorp decreased their target price on HCA Healthcare from $420.00 to $370.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. StockNews.com lowered HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Wednesday, April 9th. Robert W. Baird reaffirmed a "neutral" rating and set a $336.00 price target (down previously from $396.00) on shares of HCA Healthcare in a research note on Tuesday, April 15th. Cantor Fitzgerald reiterated an "overweight" rating and set a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Finally, Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 15th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eleven have issued a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $381.67.

HCA Healthcare Price Performance

Shares of NYSE HCA traded down $13.72 during mid-day trading on Friday, reaching $327.69. The company had a trading volume of 2,803,570 shares, compared to its average volume of 1,398,028. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The stock has a market cap of $80.68 billion, a PE ratio of 14.92, a P/E/G ratio of 1.10 and a beta of 1.48. The company has a 50-day moving average price of $329.82 and a two-hundred day moving average price of $332.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $6.45 earnings per share for the quarter, beating analysts' consensus estimates of $5.77 by $0.68. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. The company had revenue of $18.32 billion for the quarter, compared to the consensus estimate of $18.26 billion. During the same quarter in the prior year, the company earned $5.36 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 16th will be issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a yield of 0.88%. HCA Healthcare's dividend payout ratio (DPR) is currently 13.11%.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the business's stock in a transaction on Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company's stock, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.